Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.3700
-0.2350 (-38.84%)
At close: Jun 6, 2025, 4:00 PM
0.4200
+0.0500 (13.51%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $336 → $176 | Strong Buy | Maintains | $336 → $176 | +47,467.57% | May 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $256 → $336 | Strong Buy | Maintains | $256 → $336 | +90,710.81% | Dec 19, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $1,920 | Buy | Maintains | $1,920 | +518,818.92% | May 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $2,400 → $1,920 | Buy | Maintains | $2,400 → $1,920 | +518,818.92% | Mar 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $4,080 | Buy | Initiates | $4,080 | +1,102,602.70% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $4,080 | Buy | Initiates | $4,080 | +1,102,602.70% | Apr 30, 2021 |